J. D. Cheng

Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.

B. Werness, J. Babb, N. Meropol, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Recent advances in immunotherapy and monoclonal antibody treatment of cancer.

G. Adams, L. Weiner, M. von Mehren, 2000, Seminars in oncology nursing.

Impact of quality of life on patient expectations regarding phase I clinical trials.

K. Schulman, J. Rowland, B. Koczwara, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

R. Berger, J. Edenfield, W. Dalton, 2014, British Journal of Cancer.

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies.

M. von Mehren, M. Mehren, E. Bayever, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours.

P. Munster, S. Piha-Paul, A. Hollebecque, 2015, European journal of cancer.